Abstract
Asbestos has been known for many years to cause a range of both non-malignant and malignant diseases. Over fifty countries have totally banned the use of asbestos, but in emerging economies there continues to be considerable use of asbestos. Unfortunately, the United States is one of the very few developed countries that has not banned the use of this material due to industry intransigence. With the continued use of asbestos because of the lack of a worldwide ban there can be expected to be disease well into the future, for at least fifty more years, due to the long latency period for disease development. Stopping the use of asbestos has been shown to decrease the incidence, as seen in Sweden, of disease and is clearly the recommended path forward.
Keywords: Asbestos, chrysotile, amphibole, international ban, cancer, fibrosis.
Current Respiratory Medicine Reviews
Title:Asbestos-Related Diseases: Still a Concern in Emerging Economies in the Absence of an International Ban
Volume: 12 Issue: 1
Author(s): Arthur L. Frank
Affiliation:
Keywords: Asbestos, chrysotile, amphibole, international ban, cancer, fibrosis.
Abstract: Asbestos has been known for many years to cause a range of both non-malignant and malignant diseases. Over fifty countries have totally banned the use of asbestos, but in emerging economies there continues to be considerable use of asbestos. Unfortunately, the United States is one of the very few developed countries that has not banned the use of this material due to industry intransigence. With the continued use of asbestos because of the lack of a worldwide ban there can be expected to be disease well into the future, for at least fifty more years, due to the long latency period for disease development. Stopping the use of asbestos has been shown to decrease the incidence, as seen in Sweden, of disease and is clearly the recommended path forward.
Export Options
About this article
Cite this article as:
Frank L. Arthur, Asbestos-Related Diseases: Still a Concern in Emerging Economies in the Absence of an International Ban, Current Respiratory Medicine Reviews 2016; 12 (1) . https://dx.doi.org/10.2174/1573398X11666151026222515
DOI https://dx.doi.org/10.2174/1573398X11666151026222515 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pharmacological Interventions for the Prevention and Treatment of Kidney
Injury Induced by Radiotherapy: Molecular Mechanisms and Clinical
Perspectives
Current Molecular Pharmacology DLX6-AS1: An Indispensable Cancer-related Long Non-coding RNA
Current Pharmaceutical Design Biology and Impact of Signal Transducers and Activators of Transcription and Their Regulators as Targets in Cancer Therapy
Current Signal Transduction Therapy NBN Polymorphysms and Cancer Susceptibility: A Systematic Review
Current Genomics Molecular and Biochemical Pathways Encompassing Diabetes Mellitus and Dementia
CNS & Neurological Disorders - Drug Targets Targeting Tumors with Small Molecule Peptides
Current Cancer Drug Targets Old Wine in a New Bottle: The Warburg Effect and Anticancer Mechanisms of Resveratrol
Current Pharmaceutical Design Cardiovascular Effects of EGFR (Epidermal Growth Factor Receptor) Monoclonal Antibodies
Cardiovascular & Hematological Agents in Medicinal Chemistry MicroRNAs in Human Virus Genomes: Helping Hands for Viral Infection
MicroRNA Combinations of Plant Polyphenols & Anti-Cancer Molecules: A Novel Treatment Strategy for Cancer Chemotherapy
Anti-Cancer Agents in Medicinal Chemistry The Potential for Substance P Antagonists as Anti-Cancer Agents in Brain Tumours
Recent Patents on CNS Drug Discovery (Discontinued) Pharmacokinetics-based Dose Management of 5-Fluorouracil Clinical Research in Advanced Colorectal Cancer Treatment
Mini-Reviews in Medicinal Chemistry The Typical Metabolic Modifiers Conferring Improvement in Cancer Resistance
Current Medicinal Chemistry Genomics of Addiction
Current Psychiatry Reviews The Neurotachykinin NK1 Receptor – A Novel Target for Diagnostics and Therapy
Current Molecular Imaging (Discontinued) MicroRNAs: An Apparent Switch for High-Altitude Pulmonary Edema
MicroRNA Gold Nanorods are Selective Cytotoxic Agents
Anti-Cancer Agents in Medicinal Chemistry Photosensitizers Mediated Photodynamic Inactivation Against Virus Particles
Mini-Reviews in Medicinal Chemistry From HPV Infection to Oncogenesis: A Brief Review of the Complex Immunobiological Events
Current Cancer Therapy Reviews <i>Zanthoxylum bungeanum</i> Seed Oil Elicits Autophagy and Apoptosis in Human Laryngeal Tumor Cells via PI3K/AKT/mTOR Signaling Pathway
Anti-Cancer Agents in Medicinal Chemistry